WVP
DXCM icon

Worth Venture Partners’s DexCom DXCM Stock Holding History

Worth Venture Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,376
Closed -$304K – 158
2022
Q1 		$304K Buy
2,376
+496
+26% +$54.3K 0.14% 99
2021
Q4 		$252K Buy
1,880
+200
+12% +$28.7K 0.12% 100
2021
Q3 		$230K Buy
+1,680
New +$212K 0.1% 101

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Worth Venture Partners's DXCM Position: Q2 2022 in Review

Worth Venture Partners sold out of DexCom (DXCM) in Q2 2022, closing a stake of 2,376 shares — an estimated $304K sold.

Worth Venture Partners first reported a position in DXCM in Q3 2021 and held it in 3 quarters. The position peaked at $304K in Q1 2022. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Worth Venture Partners reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Worth Venture Partners sold 2,376 DexCom shares in Q2 2022, an estimated $304K.
  • Worth Venture Partners first reported a position in DexCom in Q3 2021 and held it in 3 quarters.
  • Worth Venture Partners's DexCom position peaked at $304K in Q1 2022.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Worth Venture Partners's 13F filing for Q2 2022, filed 15 Aug 2022.